BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Torque Pops Out of Stealth Mode With $25M and Rhythm Pharma Founder at Its Helm

  The financing was by Flagship Pioneering.

  November 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Embattled Mylan Chops Another 200 to 300 Jobs

  Two days after Mylan CEO Heather Bresch said she sees a “strong finish” for the company through the rest of 2017, the company has reportedly let 200 to 300 people go from its West Virginia operations.

  November 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense

  Investors love to speculate on M&A, and one of the hottest topics of speculation recently has been whether someone will buy BMS.

  November 14, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  It’s Official: President Trump Names Former Eli Lilly Exec HHS Secretary

  Alex Azar was head of U.S. operations for Lilly until January.

  November 14, 2017

   · 

  1 min read
• 

  Biotech Beach

  World’s Richest Doctor Soon-Shiong Spots a New Business Opportunity - and It’s Tumor-Related

  Will a boom in genetic testing of tumors be a boon for Soon-Shiong?

  November 14, 2017

   · 

  1 min read
• 

  Pharm Country

  3 Biotech Stars Investors Should Load Up On in November

  At 14.1%, healthcare is the third largest weighted sector in the S&P 500 index, and with 76 million baby boomers getting older and living longer, owning healthcare stocks in your portfolio makes sense.

  November 14, 2017

   · 

  1 min read
• 

  Drug Development

  Amgen’s Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks

  New data shows Repatha hit its primary endpoint and significantly reduced first-time cardiovascular events by 27 percent in PAD patients.

  November 14, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Loxo Oncology Lands $1.55B Cancer Tie-Up With Bayer

  Loxo Oncology struck a deal with Bayer to develop and commercialize two cancer therapies in a deal that could be worth up to $1.55B.

  November 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Meet the 4 Biotechs That are Disrupting Healthcare

  It’s not always easy to see when a company is a “disruptor,” which is to say, that it causes a paradigm shift in how an industry operates.

  November 14, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  New GE CEO to Focus on 3 Key Units, Exit Most Other Operations

  The company will focus on its biggest divisions: aviation, power and healthcare.

  November 14, 2017

   · 

  1 min read